Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Addtech Repurchase of own shares

Addtech has on September 14, 2022, repurchased 74,000 of its own class B shares at an average price of SEK 155.295 and on September 15, 2022, repurchased 126,000 of its own class B shares at an average price of SEK 155.200. The total number of shares held in treasury amounts to 3,368,272 class B shares. As of September 15, 2022, the total number of shares in Addtech AB amounts to 272,793,984, and the number of shares outstanding is 269,425,712. Stockholm, September 15, 2022 Addtech AB (publ) For more information, please contactMalin Enarson, CFO,+46 705 97 94 73 Addtech

Eltel signs its largest fibre agreement ever – contract value of EUR 200 million

Eltel Finland has signed a frame agreement with Valokuitunen, a joint venture between CapMan Infra and Telia, to build fibre to the home, FTTH. The agreement is worth about EUR 200 million over a three-year period, and includes an option of one additional year.Eltel and Valokuitunen will work in close partnership, where Eltel will be responsible for project management, material management and logistics, fibre network construction, installation service works and documentation. Eltel’s scope of work will also include maintenance and life-cycle services. Eltel and Valokuitunen have worked

Teleste launches S-ARRIVE software for uninterrupted on-board passenger information

TURKU, FINLAND – 15 September 2022 – Teleste is thrilled to launch S-ARRIVE®, a product-based software solution for rolling stock manufacturers and public transport operators looking to deliver seamless and uninterrupted on-board services. The software has been designed to address the growing need to increase public transport ridership by providing passengers with real-time passenger information and an excellent door-to-door travel experience. It also enables public transport operators to grow an effective transport ecosystem through integration with other on-board systems. Teleste is

Reminder regarding extraordinary general meeting and record date for participation in rights issue

The board of directors of Calmark Sweden AB (publ) (“Calmark” or the “Company”) has invited the shareholders to an extraordinary general meeting to be held on September 22, 2022, to resolve on the board's decision to issue units consisting of B shares and warrants with preferential rights for Calmark's existing shareholders (the “Rights Issue”). The record date for the Rights Issue is September 27, 2022. This implies that the last day for trading in the Company's B share with the right to participate in the Rights Issue is September 23, 2022, i.e., the day after the extraordinary general

Orkla ASA – Issuance of Commercial Paper

Orkla ASA has issued a new commercial paper of NOK 600,000,000.Start date:                   19 September 2022 Maturity:                     19 October 2022 Coupon:                      2.747% Organised by:             Handelsbanken Capital Markets     Orkla ASA Oslo, 15 September 2022     Ref.: Senior Vice President Group Treasury Geir Solli Tel.: +47 995 42 789

Food-tech company Big Akwa receives financing to accelerate growths

The company announced that they have received  SEK 2,660,000  from Almi Invest, Sparbanksstiftelsen Norrlands Riskkapitalstiftelse and 2 private investors.Big Akwa is a food-tech company developing  sustainable protein production by using industrial waste. It plans to build a land-based fish farm with an annual capacity of 3000 tons in industrial symbioses with the other enterprises in Västernorrland.   -          It’s a great honor to partner  with such established and professional investors such as Almi Invest and Sparbanksstiftelsen. Collaboration contributes to Big Akwa's strategy

Notice convening YIT Corporation’s Extraordinary General Meeting

YIT Corporation Stock exchange release 15 September 2022 at 12:30 p.m.Notice convening YIT Corporation’s Extraordinary General Meeting The shareholders of YIT Corporation are invited to attend the Extraordinary General Meeting to be held on Thursday, October 6, 2022, starting at 2:30 p.m. (Finnish time GMT+3) in Messukeskus Siipi, located at the address Rautatieläisenkatu 3, 00520 Helsinki. Check-in for those who have registered for the meeting and the distribution of ballots will start at the venue at 2:00 p.m. There will be no catering at the meeting. A. Matters to be

Enersense begins reporting on the development of its onshore wind power projects — target to build 600MW of own energy production by 2027

Enersense International PlcStock exchange release 15 September 2022 at 12.00 p.m.Enersense International Plc, a provider of zero-emission energy solutions, will start reporting on the project development portfolio of Megatuuli Oy, a leading onshore wind power project development company, semi-annually as part of its regular H1 and H2 financial reporting. Enersense completed the acquisition of Megatuuli on 1 February 2022 and owns 100 % of the company. Megatuuli Oy's project portfolio is currently 3,000MW, of which 1,500MW is in cooperation with Valorem and is divided as follows: -

Disadvantaged population groups perceive their capabilities to promote individual health and wellbeing as weak

Young people not in education, employment or training, long-term unemployed, people with refugee backgrounds, and older people living alone and at risk of exclusion perceive their capabilities to promote their individual health and wellbeing as weak. A new study shows that these people also perceived their quality of life to be weaker than the Finnish population on average. The study, conducted by Research Director Tomi Mäki-Opas and Professor Marja Vaarama at the University of Eastern Finland and by Professor Richard Pieper at Tampere University, employed the capability framework, which

3ngage to Focus on Simulation of Consumer Products – Hires Retail Experience Veteran Jon Feeney as Global Head of Sales

Consumer Experience professional Jon Feeney, who has worked on the retail and e-commerce strategies for global brands including Nike, Salomon, and Suunto, will enhance 3ngage’s relevance to all facets of the consumer journey.3ngage, a platform that lets manufacturers simulate complex consumer products in digital and physical retail channels, will now become even more relevant to leading brands who look to improve and digitalize their consumer buying journeys. Bringing digital touch-to-try capabilities to consumer brands 3ngage leads in its category, as the platform doesn’t just

Inhalation Sciences signs IRS contract worth 1.39 million SEK with new US respiratory pharma client

ISAB’s contract research organization Inhalation Research Services (IRS), has signed a new contract worth 1.39 million SEK (130K Euros) with a US respiratory pharmaceutical company. The new client has chosen ISAB’s unique in vitro lung simulation tool DissolvIt[®] for its project.The current client is a developer of new small molecule treatments for a wide range of respiratory diseases including asthma and COPD. The company has chosen to run dissolution tests on a new substance using ISAB’s leading in vitro lung simulation tool DissolvIt[®]. DissolvIt[®] has been increasingly recognized

Correction MAR label -Prostatype[®] shows strong data in Asian pilot study

The correction refers to the MAR label. This press release should be with MAR label -Selected for presentation at the Chinese Urology Association’s national congress With the second independent pilot study in the East Asia region showing strong clinical performance, Prostatype Genomics is now reviewing commercialization opportunities in the region.The recent study was conducted in China in collaboration with the Nanjing Drum Tower University Hospital, Jiangsu, and Prostatype Genomics’ partner GloriousMed based in Shanghai. The study indicates that the clinical performance of

Eficode Sweden appoints both a new Country Manager, and its first Head of People and Culture

While Therese Lindepil becomes Country Manager, her predecessor, Christian Johansson, steps into a new role focusing on developing people and culture both at Eficode and among its clients.Stockholm, September 15, 2022 – Eficode today announced Therese Lindepil as the new Country Manager of its Swedish operations. As a part of Eficode’s journey of expansion, a new role has also been created—Head of People and Culture—which former Eficode Sweden Country Manager, Christian Johansson, will be stepping into.  In recent years, Eficode has enjoyed significant growth ,

Read original

New article brings forward support for home dialysis in connection with comorbidities

Redsense Medical notes that a new scientific article is presenting emerging evidence that strengthens the case for home hemodialysis over in-center treatment. Home hemodialysis is the treatment modality in which Redsense’s solutions, which enhance patient safety by automatically and autonomously monitoring the integrity of the blood circuit, provide the most benefit. The article can be found at: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001088 The American Heart Association (AHA), a US non-profit known for publishing guidelines on cardiovascular disease (CVD) and the country’

First day of trading in Railway Metrics and Dynamics

Today is the first day of trading in the technology company Railway Metrics and Dynamics ("RMD"). The company has developed and sells a system platform for real-time analysis and monitoring of transport and infrastructure.Founded in 2011, RMD is a Stockholm-based technology company that has developed a comprehensive systems platform for transport and infrastructure analysis and monitoring. The system platform is based on a patented sensor technology based on algorithms and artificial intelligence through which the user can monitor, for example, locomotives, train carriages or railway

Prostatype[®] shows strong data in Asian pilot study

-Selected for presentation at the Chinese Urology Association’s national congress With the second independent pilot study in the East Asia region showing strong clinical performance, Prostatype Genomics is now reviewing commercialization opportunities in the region.The recent study was conducted in China in collaboration with the Nanjing Drum Tower University Hospital, Jiangsu, and Prostatype Genomics’ partner GloriousMed based in Shanghai. The study indicates that the clinical performance of Prostatype® in East Asian population is in line with the results previously communicated results

Today Agneta Palmér joins Getinge’s executive team

Four years after joining Getinge, Agneta Palmér today takes up her new role as EVP Operational Services and member of the Executive Team. For her, it is a privilege to be part of a company and an industry that evolves health care and helps save lives. “I entered the field of medtech when I joined Getinge four years ago. The values within medtech and especially Getinge resonate with my own ambitions. I like the direction we are going in, as well as the entrepreneurial spirit and to be part of taking responsibility in the greater society,” says Agneta Palmér. Today, Agneta steps

Gasum signs a 10-year PPA with Umicore on wind power

Gasum has agreed to deliver Umicore wind-power generated electricity through a power purchase agreement (PPA). The 10-year contract, commencing in 2025, includes 45 GWh of electricity annually to Umicore’s site in Kokkola, Finland.Gasum has signed a power purchase agreement or PPA with Umicore to supply them with renewable electricity. The electricity will be delivered to Umicore’s site in Kokkola, Finland. The 10-year contract of wind generated energy starts in 2025 and includes 45 GWh annually. Umicore, a Belgian company with over 200 years of history, is a global leader in clean

Orthex has started using renewable raw materials in its SmartStore™ Compact storage products

Orthex Corporation, Press Release 15 September 2022 at 11.00 a.m. EESTOrthex wants to give consumers the opportunity to choose more environmentally friendly products and has started using renewable raw materials in the production of its popular SmartStore™ Compact and Compact Clear storage boxes. The raw materials used are produced by applying a so-called mass balance approach. The mass balance approach means that renewable materials are mixed with fossil materials in the raw material production process. This reduces the amount of fossil-based plastic in the world. The mass balance

Cantargia: Oral presentation of new preclinical CAN10 efficacy data in systemic sclerosis at ACR Convergence

Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported new preclinical data demonstrating efficacy of its anti-inflammatory IL1RAP-binding antibody CAN10 in an additional model of systemic sclerosis. CAN10 alleviated disease manifestations in this model, which is one of the most commonly used models of the disease. These findings will be presented in an oral presentation at the annual rheumatology conference ACR Convergence, held in Philadelphia, November 10-14, 2022.“CAN10 continues to demonstrate promising effects in preclinical models of systemic sclerosis and the new data

Orkla acquires leading Polish pizza chain

Orkla has entered an agreement to acquire 74% of the shares in Da Grasso, one of the leading pizza franchise chains in Poland with 193 outlets nationwide.Consumer sales for the chain in 2021 amounted to EUR 53 million, which corresponds to approximately NOK 530 million. Da Grasso had a turnover of EUR 13.6 million in 2021 (NOK 136 million). Normalized EBITDA amounted to EUR 2.5 million in 2021 (NOK 25 million). Da Grasso was established in 1996. The company is headquartered in Łódź and has 51 employees. "Da Grasso is a well-run business that has built an impressive position in the

SRV Group Plc's financial reporting in 2023

SRV GROUP PLC     STOCK EXCHANGE RELEASE     15 SEPTEMBER 2022     11:00 EEST SRV Group Plc's financial reporting in 2023 SRV Group Plc's Financial Statements Bulletin for the year 2022 will be published on Thursday 2 February 2023 at 8:30 a.m. SRV’s Annual Report for 2022 will be published on Wednesday 1 March 2023. In addition, SRV will publish three interim reports in 2023: · January-March on Thursday 27 April 2023 at 8:30 a.m. · January-June on Thursday 20 July 2023 at 8:30 a.m. · January-September Thursday 26 October 2023 at 8:30 a.m. SRV Group Plc's Annual

Norse Atlantic Airways Launches Global Sale

Today, Norse Atlantic Airways launched the great getaway sale with 30,000 seats in Premium and Economy available across all destinations*.“There has never been a better time to book a long weekend city break or to plan the holiday of lifetime thanks to the Norse Atlantic Airways sale. Passengers can enjoy direct flights onboard state of the art Boeing 787 Dreamliners and explore further for less with Norse Atlantic,” said Andrew Hodges, Chief Commercial Officer Norse Atlantic Airways. The large and spacious Boeing 787 Dreamliner cabin offers passengers a relaxed and comfortable travel

Photocure Partner Asieris announces coverage of Hexvix by the Lecheng Global Specialty Drug Insurance

Press release – Oslo, Norway, September 15, 2022: Photocure ASA (PHO: OSE), The Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today on the inclusion of Hexvix[®] in the 2022 edition of the Lecheng Global Specialty Drug Insurance Specialty Drug List.As a new specialty drug benefit plan developed under the guidance of the government covering 40 domestic specialty drugs and 60 overseas specialty drugs, the Lecheng Global Specialty Drug Insurance allows Hainan citizens access to more advanced medical resources and comprehensive

There are no items matching the current filter
There are no more items matching the current filter
Back to top